Emergent reshuffles its manufacturing brain trust as CEO sends mixed messages around Covid-19 vaccine debacle

Josh Sullivan

Weeks after Maryland-based Emergent BioSolutions bungled 15 million doses of J&J’s Covid-19 shot and was shut out of its own Baltimore facility, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Emergent reshuffles its manufacturing brain trust as CEO sends mixed messages around Covid-19 vaccine debacle

Josh Sullivan

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Emer­gent reshuf­fles its man­u­fac­tur­ing brain trust as CEO sends mixed mes­sages around Covid-19 vac­cine de­ba­cle

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Emergent reshuffles its manufacturing brain trust as CEO sends mixed messages around Covid-19 vaccine debacle